Tet 2 loss leads to hypermutagenicity in haematopoietic stem / progenitor cells

[1]  Viren Patel,et al.  PEMapper and PECaller provide a simplified approach to whole-genome sequencing , 2017, Proceedings of the National Academy of Sciences.

[2]  She Chen,et al.  Cooperative Action between SALL4A and TET Proteins in Stepwise Oxidation of 5-Methylcytosine. , 2016, Molecular cell.

[3]  A. Klungland,et al.  Biochemical reconstitution of TET1–TDG–BER-dependent active DNA demethylation reveals a highly coordinated mechanism , 2016, Nature Communications.

[4]  Zhigang Zhao,et al.  The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells , 2016, Leukemia.

[5]  R. Jaenisch,et al.  Combined Loss of Tet1 and Tet2 Promotes B-Cell, but Not Myeloid Malignancies in Mice , 2015 .

[6]  Yi Zhang,et al.  Charting oxidized methylcytosines at base resolution , 2015, Nature Structural &Molecular Biology.

[7]  S. Miyano,et al.  CLINICAL AND BIOLOGICAL IMPLICATIONS OF ANCESTRAL AND NON-ANCESTRAL IDH1 AND IDH2 MUTATIONS IN MYELOID NEOPLASMS , 2015, Leukemia.

[8]  Chuan He,et al.  Base-resolution maps of 5-formylcytosine and 5-carboxylcytosine reveal genome-wide DNA demethylation dynamics , 2015, Cell Research.

[9]  J. M. Wessels,et al.  Many roads lead to Rome [blog] , 2014 .

[10]  J. Swenberg,et al.  Guanine- 5-carboxylcytosine base pairs mimic mismatches during DNA replication , 2014, Scientific Reports.

[11]  William A. Pastor,et al.  Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells , 2014, Proceedings of the National Academy of Sciences.

[12]  Yi Zhang,et al.  TET enzymes, TDG and the dynamics of DNA demethylation , 2013, Nature.

[13]  S. Miyano,et al.  Somatic SETBP1 mutations in myeloid malignancies , 2013, Nature Genetics.

[14]  C. Hother,et al.  Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma , 2013, Haematologica.

[15]  Wei Yang,et al.  The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα , 2013, Cell.

[16]  P. Jin,et al.  Genome-wide Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming , 2013, Cell.

[17]  Richard A. Moore,et al.  The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma. , 2013, Blood.

[18]  Robert Huether,et al.  The genomic landscape of hypodiploid acute lymphoblastic leukemia , 2013, Nature Genetics.

[19]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[20]  F. Bertucci,et al.  Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms , 2012, Genes, chromosomes & cancer.

[21]  N. Socci,et al.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. , 2012, The New England journal of medicine.

[22]  S. Daignault,et al.  TET2 and DNMT3A Mutations in Human T-Cell Lymphoma , 2012 .

[23]  J. Vijg,et al.  Measuring Genome Instability in Aging – A Mini-Review , 2011, Gerontology.

[24]  Feng-Chun Yang,et al.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.

[25]  S. Sugano,et al.  Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.

[26]  Chuan He,et al.  Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.

[27]  Yang Wang,et al.  Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA , 2011, Science.

[28]  A. Maiti,et al.  Thymine DNA Glycosylase Can Rapidly Excise 5-Formylcytosine and 5-Carboxylcytosine , 2011, The Journal of Biological Chemistry.

[29]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[30]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[31]  P. Jin,et al.  Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine , 2011, Nature Biotechnology.

[32]  L. Aravind,et al.  Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 , 2010, Nature.

[33]  David J. Cutler,et al.  SeqAnt: A web service to rapidly identify and annotate DNA sequence variations , 2010, BMC Bioinformatics.

[34]  Yi Zhang,et al.  Active DNA demethylation: many roads lead to Rome , 2010, Nature Reviews Molecular Cell Biology.

[35]  R. Levine,et al.  Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.

[36]  A. Hagemeijer,et al.  Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.

[37]  Jungwon Huh,et al.  Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. , 2009, Blood.

[38]  D. Gilliland,et al.  TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis , 2009, Leukemia.

[39]  M. Tahiliani,et al.  MLL Partner TET1 5-Hydroxymethylcytosine in Mammalian DNA by Conversion of 5-Methylcytosine to , 2009 .

[40]  T. Lister,et al.  Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease , 2008, Proceedings of the National Academy of Sciences.

[41]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[42]  R. Scott Hansen,et al.  Hairpin-bisulfite PCR: Assessing epigenetic methylation patterns on complementary strands of individual DNA molecules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Barnes,et al.  Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas , 2003, Oncogene.

[44]  W. Edelmann,et al.  Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[46]  G. Coetzee,et al.  5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. , 1990, Science.